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Abstract Competing risks model time to first event and type of first
event. An example from hospital epidemiology is the incidence of hospital-
acquired infection, which has to account for hospital discharge of non-infected
patients as a competing risk. An illness-death model would allow to further
study hospital outcomes of infected patients. Such a model typically relies
on a Markov assumption. However, it is conceivable that the future course
of an infected patient does not only depend on the time since hospital ad-
mission and current infection status but also on the time since infection. We
demonstrate how a modified competing risks model can be used for nonpara-
metric estimation of transition probabilities when the Markov assumption is
violated.
Keywords: Left-truncation · Bivariate survival · Nosocomial Infection ·
Markov assumption · Multi-state model
1 Introduction
A competing risks model considers time to first event and type of first event.
In real life, one competing event, say event 1, may be intermediate, and it
could be of interest to investigate subsequent occurrence of event 2. This is
feasible by extending the competing risks model to an illness-death model.
The idea is that all individuals are initially subject to the original competing
risks experiment. For those individuals who had a type 1 event as a first
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event, a second experiment determines the waiting time between the type 1
event and the type 2 event. See Fine et al. (2001) for a related extension of
competing risks.
Both competing risks and illness-death models are, for instance, rele-
vant in hospital epidemiology (Beyersmann et al., 2011): Nosocomial, i.e.,
hospital-acquired infections are a major healthcare concern, increasing mor-
bidity and mortality, and they are a problem from a health economics per-
spective. Umscheid et al. (2011) considered preventable nosocomial infec-
tions and argued that successful prevention could save up to 53,483 lives a
year in the U.S., with up to $23.44 billion annual cost savings to hospitals.
Grambauer et al. (2010) recently demonstrated that estimating the inci-
dence of nosocomial infections must account for end of hospital stay without
prior infection as a competing risk, i.e., direct discharge of a patient prevents
in-hospital infection. Predicting length of hospital stay for an infected patient
or predicting the proportion of infected in-hospital patients is relevant for the
planning of hospital resources, but must account for the time-dependency of
the infection status as in an illness-death model (Graves et al., 2011). In
this model, all patients would share one initial state. Infected patients move
into the intermediate illness state at the time of infection, and end of stay is
modelled by transitions into the absorbing state.
The canonical nonparametric estimator of the transition probabilities in
these models is the Aalen-Johansen estimator (Aalen and Johansen, 1978).
The estimator relies on a time-inhomogeneous Markov assumption, which is
trivially fulfilled for competing risks, but may be violated in an illness-death
model. In the context of nosocomial infections, the assumption does not
hold, if the end-of-hospital stay probability of an infected patient depends
on the time of infection.
Research for possibly non-Markov models has mostly focused on esti-
mating state occupation probabilities P (Xt = j), where Xt denotes the state
occupied at time t and j is a possible state of the model. Under a Markov as-
sumption and assuming one initial state occupied by all individuals at time 0,
say P (X0 = 0) = 1, estimation may be based on the Aalen-Johansen esti-
mator of P (Xt = j |X0 = 0). In the absence of a common initial state, the
Aalen-Johansen estimator of P (Xt = j |X0 = ·) would need to be multiplied
by an estimator of the initial state distribution.
For complete data, Andersen et al. (1993) showed that this approach
equals the usual multinomial estimators which do not rely on a Markov as-
sumption. A major breakthrough for data subject to random right-censorship
was then obtained by Datta and Satten (2001) and Glidden (2002). Datta
and Satten showed that this Aalen-Johansen approach still consistently es-
timates the state occupation probabilities in the absence of the Markov
2
property, and Glidden provided weak convergence results. Earlier work of
Pepe et al. (1991) had allowed for estimating the probability of an intermedi-
ate condition in a non-Markov illness-death model. Interestingly, Pepe et al.
found their estimator to approximately equal the standard Aalen-Johansen
estimator, somewhat anticipating the subsequent more general results of
Datta and Satten.
Datta and Satten (2002) allowed for non-random censoring by directly
modelling the censoring hazard; see also related results by Datta et al. (2000)
for the illness-death model. Gunnes et al. (2007) discussed the relative mer-
its of the Aalen-Johansen and the Datta-Satten estimator in terms of bias and
mean squared error in the presence of dependent censoring. See Datta and Ferguson
(2012) for an overview.
A different line of research that could be applied to non-Markov mul-
tistate models is time-multivariate survival analysis. Gill (1992) mentions
this possibility and gives an insightful discussion on why nonparametric es-
timation of a multivariate survival function in the presence of multivariate
censoring is a difficult problem, where the usual counting process approach
breaks down. Lin and Ying (1993) noted that the difficulties reduce and
simpler estimation procedures are feasible, if censoring is univariate. This is
the case in a multistate model. Tsai and Crowley (1998) improved on the
Lin-Ying estimator, and an overview was given by Prentice et al. (2004).
The aim of the present paper is to use competing risks techniques for non-
parametric estimation of transition probabilities in a potentially non-Markov
illness-death model without recovery. This aim differs from estimating state
occupation probabilities P (Xt = j) in that we do wish to condition on the
state occupied at time s, s ≤ t. There is a connection to time-multivariate
survival analysis, because the first estimator that we will derive is alge-
braically identical to an earlier proposal by Meira-Machado et al. (2006). To
the best of our knowledge, the work by Meira-Machado et al. was the first
paper which focused on using time-multivariate techniques for estimation of
transition probabilities in a non-Markov illness-death model, employing the
time-multivariate techniques of Stute (1993).
We develop the Meira-Machado et al. estimator via a different route,
which allows for a competing risks explanation on why their estimator works
in a non-Markov model. We also give a new inverse probability of censor-
ing weighted (IPCW) representation of the estimator. Using both the new
IPCW representation and results of Tsai and Crowley (1998), we derive a
new, simpler and theoretically more efficient competing risks-type estimator.
The new estimator gives direct access to competing risks methodology, which
we demonstrate by also allowing for left-truncation.
The paper is organized as follows: Section 2 introduces competing risks
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and illness-death models as stochastic processes. The illness-death model
is also re-parametrized via a bivariate time vector and a further competing
risks model is derived, which will be crucial for the nonparametric estima-
tion procedures of Section 3. We report simulation results in Section 4 and
an analysis of real hospital infection data in Section 5. The closing Sec-
tion 6 offers a discussion, including an appraisal of the relative merits of the
Meira-Machado et al. estimator and the new competing risks estimator. Our
conclusion is that both estimators perform comparably, but that the new
estimator may be preferred due to its computational simplicity. We also find
that the Aalen-Johansen estimator may perform competitively even if the
Markov assumption is violated.
2 Competing risks and illness-death models
Consider a stochastic process (Xu)u∈[0,∞) with state space {0, 1, 2}, right-
continuous sample paths and initial state 0, P (X0 = 0) = 1. For a competing
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Figure 1: Competing risks model and illness-death model without recovery.
risks model with two competing risks, we model 0→ 1 and 0→ 2 transitions,
and states 1 and 2 are absorbing, i.e., there are no transitions out of the
absorbing states. In the context of nosocomial infections, we will consider
patients to enter state 0 on admission to hospital. Occurrence of an infection
is modelled by a 0→ 1 transition, end of hospital stay without prior infection
is modelled by a 0→ 2 transition.
We may extend this model to an illness-death model without recovery by
also allowing for 1 → 2 transitions. This is illustrated in Figure 1, where
the dashed arrow indicates that 1 → 2 transitions are only feasible in the
illness-death model. The addendum ‘without recovery’ means that 1 → 0
transitions are not modelled. For nosocomial infections, this entails that
Xu = 1 is interpreted as ‘in hospital at time u, infection has occurred in (0, u]’.
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This interpretation is in line with the common comparison of infected ‘cases’
and non-infected ‘controls’ in hospital epidemiology. The interpretation of
Xu = 2 is that hospital stay has ended by time u.
Also note that the interpretation of states 1 and 2 differs between the
models. For competing risks, the interpretation of state 1 is ‘an infection
has occurred’, while the interpretation of state 2 is ‘hospital stay has ended
without prior infection’.
Regardless of the model, we may define the time until first event,
T0 = inf{u : Xu 6= 0}. (1)
The type of first event is
XT0 ∈ {1, 2}, (2)
the state entered by the process at time T0.
For the illness-death model, we also define the time until absorption (end
of hospital stay),
T = inf{u : Xu = 2}. (3)
We have T0 = T , if the process makes a direct 0→ 2 transition, and T0 < T
otherwise. We assume that the distribution of T has mass on [0,∞) only.
That is, every individual reaches state 2 (spends a finite time in hospital).
In the remainder of the paper, we will take (Xu)u to be an illness-death
model. The aim will be to provide for non-parametric estimation of the
transition probabilities
Plj(s, t) = P (Xt = j |Xs = l), (4)
where (s, t), s ≤ t, is a fixed, but arbitrary pair of times, l ∈ {0, 1}, j ∈ {1, 2}.
In (4), we do not assume that conditioning on Xs = 1 is tantamount to
conditioning on the entire past of the process up to time s. That is, we do
not assume that (Xu)u is Markov.
More specifically and for ease of presentation, we will focus on P01(s, t).
In the data example, this is the probability of an infected in-hospital patient
at time t given no infection at time s. This quantity can be used for the
planning of hospital resources. Our ideas work analogously for the other
transition probabilities. We express P01(s, t) in terms of the bivariate time
vector (T0, T ),
P01(s, t) =
P (Xt = 1, Xs = 0)
P (Xs = 0)
=
P (s < T0 ≤ t, t < T )
P (T0 > s)
. (5)
The key to the nonparametric estimation procedures in Section 3 are
both (5) and the following competing risks process (κu;s,t)u = (κu)u, which
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is derived from the illness-death process (Xu)u,
κu;s,t = κu =


0 : Xu ∈ {0, 1},
1 : Xu = 2 and 1(s < T0 ≤ t, t < T ) = 1,
2 : Xu = 2 and 1(s < T0 ≤ t, t < T ) = 0,
(6)
where 1(·) is the indicator function. The competing risks process κ stays in
its initial state 0 until time T . At time T , the value of the competing risks
mark 1(s < T0 ≤ t, t < T ) is known. We have that P (κT = 1) = P (s < T0 ≤
t, t < T ). As a consequence, the numerator of the right hand side of (5) is
the limit of the cumulative incidence function for event type 1 of κ,
P (s < T0 ≤ t, t < T ) = lim
u→∞
P (T ≤ u, κT = 1). (7)
Note that the competing risks process κ depends on the fixed, but arbitrary
pair of times (s, t), s ≤ t, but we are suppressing this in the notation for ease
of writing.
3 Nonparametric estimation
We assume that observation of the illness-death process X , or, equivalently,
of the random times (T0, T ), is subject to random censorship by C. We also
assume that the support of the distribution of T is contained in the support
of the distribution of C. This last assumption is needed for estimation of
the limit of the cumulative incidence function in (7). It is justifiable for
the nosocomial infection example, but may be violated in other settings. In
the discussion, we explain how this assumption can be relaxed. We first
revisit the estimator of Meira-Machado et al. (2006) in Section 3, revealing
that violations of the Markov assumption can be seen to be handled via a
competing risks approach and also giving a new IPCW representation of the
estimator. These two observations are taken further in Section 3.2, leading
to a simpler competing risks-type estimator, which in turn also allows for
left-truncated data as explained in Section 3.3.
3.1 The estimator of Meira-Machado et al. revisited
For estimation of (5), we use the usual Kaplan-Meier estimator for estimat-
ing the denominator P (T0 > s), based on the censored observations of T0.
Because of (7), we use the right hand limit of the Aalen-Johansen estimator
of P (T ≤ u, κT = 1) for estimation of the numerator. To this end, and for the
competing risks process κ, we write N1 for the counting process of observed
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events of type 1, N for the counting process of observed events (of any type),
and Y for the at-risk process. We also write N0 for the counting process of
observed replicates of T0 and Y0 for the at risk process of the initial state
of the illness-death model X . Note that the processes N1, N and Y depend
on the fixed pair of times (s, t) through κ, but N0 and Y0 do not depend on
(s, t). Then, these estimators are
Pˆ (T0 > s) =
v∈[0,s]
(
1−
dN0(v)
Y0(v)
)
(8)
and
Pˆ (s < T0 ≤ t, t < T ) =
∫
∞
0
v∈[0,u)
(
1−
dN(v)
Y (v)
)
dN1(u)
Y (u)
. (9)
Recall that the right hand side of (9) depends on (s, t) via N1, N and Y . In
the appendix, we show that the resulting estimator of P01(s, t),
Pˆ01(s, t) = Pˆ (s < T0 ≤ t, t < T )/Pˆ (T0 > s), (10)
equals the estimator proposed by Meira-Machado et al. (2006), who derived
their estimator via a different route, using Kaplan-Meier integrals. Note that
the estimator (10) is, in general, different from the Aalen-Johansen estimator.
This is even true for the simple case of s = 0. Here, as a function of t, the
Aalen-Johansen estimator of P01(0, t) will change its value whenever there
is an observed 0 → 1 transition in the illness-death model. In contrast,
and assuming no ties, the non-Markov estimator will not change its value
(as a function of t), if the individual at hand is subsequently censored in
the intermediate state of the illness-death model. This is so, because N1
is the counting process of observed events of type 1 of the competing risks
process κ. The event times of κ are the waiting times until absorption of the
illness-death process.
We now give a new IPCW representation of the estimator, which we will
subsequently use to modify and thereby simplify estimation of P01(s, t). The
idea is to express (9) in terms of a Kaplan-Meier estimator of the censoring
survival function and to then use an observation by Tsai and Crowley (1998),
who noted that there is more than one such estimator in bivariate time.
We write NC for the counting process of censoring events, which have
been observed before absorption. We have that
∆NC(u) + ∆N(u) + Y (u+) = Y (u),
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where ∆ indicates the increment of the respective processes. As a conse-
quence,
v∈[0,u)
(
1−
dN(v)
Y (v)
)
·
v∈[0,u)
(
1−
dNC(v)
Y (v)−∆N(v)
)
=
Y (u)
Y (0)
, (11)
and the estimator in (9) equals
1
Y (0)
∫
∞
0
v∈[0,u)
(
1−
dNC(v)
Y (v)−∆N(v)
)−1
dN1(u). (12)
Here, v∈[0,u)
(
1− dN
C(v)
Y (v)−∆N(v)
)
is the Kaplan-Meier estimator of P (C ≥ u),
based on the censored observations of T .
3.2 A new competing risks-type estimator
Tsai and Crowley (1998) observed that there is more than one Kaplan-
Meier-type estimator of P (C ≥ u), if a bivariate vector of event times such
as (T0, T ) is subject to one censoring variable C. We introduce some addi-
tional notation: We write NC0 for the counting process of censoring events,
which have been observed before leaving the initial state of the illness-death
model X . We also write sY for the at risk process of the competing risks
model κ in the data subset of individuals who were still in the initial state
of X and under observation at time s. We analogously define sN , sN1 and
sN
C . Then Tsai and Crowley suggested to use the following Kaplan-Meier-
type estimator of P (C ≥ u), specialized to our setting with T0 ≤ T ,
v∈[0,s]
(
1−
dNC0 (v)
Y0(v)−∆N0(v)
)
·
v∈(s,u)
(
1−
dsN
C(v)
sY (v)−∆sN(v)
)
. (13)
Replacing v∈[0,u)
(
1− dN
C(v)
Y (v)−∆N(v)
)
in (12) by (13) as an estimator of P (C ≥
u), we obtain a different estimator of P (s < T0 ≤ t, t < T ),
Pˇ (s < T0 ≤ t, t < T ) =
1
Y (0)
v∈[0,s]
(
1−
dNC0 (v)
Y0(v)−∆N0(v)
)−1
·
∫
∞
0
v∈(s,u)
(
1−
dsN
C(v)
sY (v)−∆sN(v)
)−1
dN1(u).
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Because Y (0) = Y0(0), Y0(s+) = sY (s+) and (as a consequence of the defi-
nition of κ) N1 = sN1, this equals
v∈[0,s]
(
1−
dN0(v)
Y0(v)
)∫
∞
s
v∈(s,u)
(
1−
dsN(v)
sY (v)
)
dsN1(u)
sY (u)
where we have also used an analogous variant of (11) for Pˆ (T0 > s) =
v∈[0,s]
(
1− dN0(v)
Y0(v)
)
.
The resulting estimator of P01(s, t) is
Pˇ01(s, t) = Pˇ (s < T0 ≤ t, t < T )/Pˆ (T0 > s)
=
∫
∞
s
v∈(s,u)
(
1−
dsN(v)
sY (v)
)
dsN1(u)
sY (u)
. (14)
The estimator in (14) is simple: It is just an estimator of the limit of a
cumulative incidence function as in (9), but evaluated in the data subset
‘still in the initial state of X and under observation at time s’.
Standard competing risks arguments can be used to derive an estimator
of the variance of Pˇ01(s, t) (Andersen et al., 1993, p. 299),
vˆarPˇ01(s, t) =∫
∞
s
{
v∈(s,u]
(
1−
dsN(v)
sY (v)
)}2{
1−
∫
∞
u
v∈(u,r)
(
1−
dsN(v)
sY (v)
)
dsN1(r)
sY (r)
}2
dsN1(u)
sY (u)
+
∫
∞
s
{
v∈(s,u]
(
1−
dsN(v)
sY (v)
)
·
∫
∞
u
v∈(u,r)
(
1−
dsN(v)
sY (v)
)
dsN1(r)
sY (r)
}2
dsN2(u)
sY (u)
,
where we have also used sN2 for the counting process of observed events of
type 2 of the competing risks model κ in the data subset of individuals who
were still in the initial state of X and under observation at time s. This
variance estimator is motivated by a corresponding asymptotic expression
(Andersen et al., 1993, p. 321.).
Theoretically, the new estimator is more efficient than the one of Meira-Machado et al.
(2006, Theorem 2). The informal argument is that it uses the full information
from the subjects whose illness-death process was right censored, whereas the
Meira-Machado et al. estimator ignores the information in which state the
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subjects were right censored. This can be seen by comparing the weights
used in the construction of the IPCW estimators (this is were information
from the censored subjects enters). The new estimator uses the conditional
weights given in (13). The first factor of (13) estimates P (C ≥ s | T0 > s)
using all censored times that are less than or equal to time s and where the
corresponding illness-death process is censored in the initial state. The sec-
ond factor estimates P (C ≥ u | T0 > s,C > s) using all the censoring times
that are greater than time s and less than or equal to time u for which the
corresponding illness-death process is in the initial state and under obser-
vation at time s. The Meira-Machado et al. estimator uses IPCW weights
derived from the marginal Kaplan-Meier estimator P (C ≥ u) which uses
the censoring times but not the state of the illness-death process at the in-
dividual censoring time. There are similar results and a general theory for
IPCW (van der Laan and Robins, 2003) which could be used to show for-
mally that Pˇ01(s, t) is asymptotically more efficient as compared to Pˆ01(s, t).
However, our simulation results and data example show comparable small
sample performances of both estimates (see Sections 4 and 5).
3.3 Left-truncated data
So far, we have assumed that observation of the illness-death process is sub-
ject to random censoring only. We now additionally allow for left-truncation
(delayed study entry), which can be handled by the new estimator Pˇ01(s, t)
because of general competing risks results (Andersen et al., 1993). To be
specific, assume that observation of the random times (T0, T ), is subject to
random left-truncation and right-censorship by (L,C), i.e., we assume that
the tuples (T0, T ) and (L,C) are independent.
We have to be precise what delayed study entry in this context means,
because Pˇ01(s, t) is an estimated cumulative incidence function, estimated in
the data subset ‘in the initial state of X and under observation at time s’.
This entails that only an individual whose left-truncation time L is less than
its waiting time T0 in the initial state can enter the calculation. This is
in contrast to standard nonparametric estimation for a time-inhomogeneous
Markov model, where an individual may be in any non-absorbing state of
the model at the time of study entry.
We now write sY for the at risk process of the competing risks model κ in
the data subset of individuals whose left-truncation times were less than s and
who were still in the initial state of X and under observation at time s. We
analogously interpret sN , sN1 and sN2. We can then profit from the general
fact that counting processes naturally account for left-truncation (Keiding,
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1992) and estimate P01(s, t) using
Pˇ01(s, t) =
∫
∞
s
v∈(s,u)
(
1−
dsN(v)
sY (v)
)
dsN1(u)
sY (u)
.
At the beginning of the section, we had been forced to assume the support of
the distribution of T to be contained in that of C, because integrals as on the
right hand side of the previous display are being evaluated up to∞. We now
need to additionally account for the presence of left-truncation. Essentially
what we need to ensure is that the risk set sY is non-empty on [s,∞) with
asymptotic probability larger than zero. To be precise, we assume that for
all u < inf{v : P (T > v) = 0} there exists a positive function y on [0, u],
bounded away from zero, such that
sup
v∈[s,u]
|sY (v)/sY (s+)− y(v)| → 0
in probability as the ‘sample size’ sY (s+) goes to infinity (Andersen et al.,
1993, Condition (4.1.16)).
4 Simulation Study
We now report results of a limited simulation study, where the aim is to com-
pare the finite sample performance of our new estimator Pˇ01(s, t) from (14)
with the more complicated estimator Pˆ01(s, t) from (10), which is algebraically
equal to the estimator of Meira-Machado et al. (2006). We also report results
from using the Aalen-Johansen estimator.
We simulated data from a scenario used by Meira-Machado et al., which
these authors found to be challenging both in terms of bias and variance. To
be specific, we generated replicates of (T0, XT0) using an exponential hazard
of 0.039 + 0.026 for simulating T0 and deciding on XT0 = 1 in a binomial
experiment with probability 0.039/(0.039 + 0.026). If XT0 = 1, we set T =
1.7 · T0; as a consequence, the model is not Markov. Random censoring
was simulated from an exponential distribution with parameters 0.013 or
0.035. In addition, we also investigated Pˇ01(s, t) when the data were subject
to both left-truncation and right-censoring. Left-truncation was simulated
from a skew normal distribution (Azzalini, 1985), with location equal to −5,
scale equal to 10 and shape equal to 10. Right-censoring was exponentially
distributed with hazard 0.013.
We simulated 1000 studies and report the bias (average of the 1000 es-
timates of P01(10, t) minus true quantity) and the empirical variance of the
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Pˇ01(10, t) Pˆ01(10, t) Aalen-Johansen
t Bias Variance Bias Variance Bias Variance
30 1.92e-03 5.07e-03 1.91e-03 5.02e-03 -2.10e-02 3.92e-03
40 4.69e-03 4.46e-03 4.74e-03 4.45e-03 -7.44e-03 3.57e-03
50 -3.33e-03 4.44e-03 -3.21e-03 4.46e-03 -5.75e-03 3.62e-03
60 -6.42e-03 3.86e-03 -6.35e-03 3.88e-03 -3.14e-03 3.08e-03
70 -1.05e-02 3.05e-03 -1.05e-02 3.06e-03 -2.90e-03 2.54e-03
80 -8.47e-03 2.39e-03 -8.49e-03 2.39e-03 1.26e-03 2.17e-03
90 -9.61e-03 1.51e-03 -9.62e-03 1.51e-03 1.71e-03 1.60e-03
100 -7.02e-03 1.11e-03 -7.03e-03 1.11e-03 5.05e-03 1.37e-03
Table 1: Simulation results for censoring hazard 0.013.
estimates. In the presence of right-censoring only, the sample size in each
simulated study was 100. With additional left-truncation, the average sample
size was 85. The true value P01(10, t) was numerically approximated based
on 100 replications of uncensored samples of size 10000 using the usual bi-
nomial estimator within the data subset defined by ‘in state 0 at time 10’,
yielding
t 30 40 50 60 70 80 90 100
P01(10, t) 0.201 0.162 0.125 0.092 0.067 0.048 0.033 0.023
Tables 1 and 2 give results for the right-censoring scenarios, table 3
displays results for the scenario subject to both left-truncation and right-
censoring.
The tables indicate similar performance of both estimators (10) and (14)
in terms of bias and variance and in the presence of right-censoring only. Sim-
ilar results were found for a sample size of 200 (not shown). Interestingly,
Tables 1 and 2 find the Aalen-Johansen estimator to perform at least com-
petitively except for the early time point 30. This is somewhat in contrast to
the results reported by Meira-Machado et al., who found the Aalen-Johansen
estimator to be biased in the absence of the Markov property. The reason is
that these authors considered the absolute bias integrated over time, which
appears to be dominated by early time points. We find a similar picture
when comparing the new estimator and the Aalen-Johansen in the presence
of additional left-truncation.
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Pˇ01(10, t) Pˆ01(10, t) Aalen-Johansen
t Bias Variance Bias Variance Bias Variance
30 3.31e-03 1.28e-02 2.92e-03 1.27e-02 -1.61e-02 7.27e-03
40 -1.14e-02 1.54e-02 -1.16e-02 1.53e-02 -4.94e-03 9.52e-03
50 -3.35e-02 1.29e-02 -3.36e-02 1.28e-02 -6.03e-03 9.48e-03
60 -3.78e-02 8.93e-03 -3.80e-02 8.82e-03 3.41e-03 8.86e-03
70 -4.14e-02 4.89e-03 -4.15e-02 4.87e-03 9.20e-03 8.55e-03
80 -3.39e-02 2.78e-03 -3.39e-02 2.75e-03 2.04e-02 8.36e-03
90 -2.75e-02 1.03e-03 -2.76e-02 1.01e-03 2.82e-02 7.74e-03
100 -2.08e-02 3.94e-04 -2.08e-02 3.86e-04 3.56e-02 7.58e-03
Table 2: Simulation results for censoring hazard 0.035.
Aalen-Johansen Pˇ01(10, t)
t Bias Variance Bias Variance
30 -2.17e-02 4.00e-03 3.18e-04 5.41e-03
40 -9.38e-03 4.03e-03 2.06e-03 5.24e-03
50 -5.30e-03 3.55e-03 -1.33e-03 4.62e-03
60 -1.38e-03 3.05e-03 -2.79e-03 4.02e-03
70 -4.83e-04 2.42e-03 -6.90e-03 3.02e-03
80 1.25e-03 2.02e-03 -8.43e-03 2.28e-03
90 2.38e-03 1.69e-03 -9.27e-03 1.59e-03
100 3.85e-03 1.38e-03 -9.10e-03 9.97e-04
Table 3: Simulation results for left truncated data and censoring hazard 0.013
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5 Real data example
We use a random subsample of 1313 patients from the SIR3 (Spread of
nosocomial I nfections and Resistant pathogens) study that has been made
publicly available as part of the R-package kmi (Beyersmann et al., 2012).
The present analyses may therefore be reproduced. SIR3 was a prospective
study to assess the occurrence and the impact of hospital-acquired infec-
tions in intensive care. Details are reported elsewhere (Beyersmann et al.,
2006). Here, we focus on the occurrence of hospital-acquired pneumonia,
which is one of the most frequent and most severe nosocomial infections. In
an analysis of the full data set of 1876 patients, Allignol et al. (2011) in-
cluded time of pneumonia as a time-dependent covariate into Cox models for
the end-of-stay hazards (distinguishing between competing endpoints alive
discharge and hospital death). Because the hazard ratios were approximately
equal to one in this informal check of the Markov assumption, these authors
concluded that one may assume the data to follow a time-inhomogeneous
Markov model. However, because the confidence intervals were marginal, a
more robust estimation procedure as in the present paper may be desirable.
Tables 4, 5 and 6 report results on estimating P01(s, t) for s = 3, s = 5
and s = 7, using both Pˆ01(s, t) and Pˇ01(s, t). These estimates are relevant
for planning hospital resources, estimating the probability of future infected
intensive care patients among the currently, i.e., at time s uninfected.
The tables also report variance estimates and 95% confidence intervals
(CI) computed from 1000 bootstrap samples. We used the bootstrap in or-
der to have one common method for both Pˆ01(s, t) and Pˇ01(s, t). Section 3
has shown that estimating a cumulative incidence function is at the core
of both Pˆ01(s, t) and Pˇ01(s, t), and recent research has investigated different
proposals for estimating the variance of an estimated cumulative incidence
function (Braun and Yuan, 2007; Allignol et al., 2010). Because of our rep-
resentations (10) and (14), the functional delta method justifies both use of
the bootstrap and of a normal limit. The tables report CIs both using the
25th and 75th quantiles of the bootstrap estimates distribution and using a
normal approximation. Similar to the simulation study in Section 4, we find
that Pˆ01(s, t) and Pˇ01(s, t) perform comparably.
Finally, Table 7 displays the point estimates Pˇ01(s, t) together with the
corresponding Aalen-Johansen estimates. Both estimators yield similar re-
sults.
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New estimator Meira-Machado estimator
t P01(s, t) Variance Bootstrap CI Normal CI P01(s, t) Variance Bootstrap CI Normal CI
5 0.0234 1.95e− 05 [0.0152; 0.0323] [0.0147; 0.032] 0.0255 1.95e− 05 [0.0168; 0.0352] [0.0162; 0.0347]
6 0.0314 2.45e− 05 [0.0219; 0.0413] [0.0217; 0.0411] 0.0342 2.45e− 05 [0.0244; 0.046] [0.0236; 0.0448]
7 0.0363 2.82e− 05 [0.0258; 0.0469] [0.0258; 0.0467] 0.0395 2.82e− 05 [0.0286; 0.0517] [0.0282; 0.0507]
8 0.0396 3.17e− 05 [0.0288; 0.051] [0.0285; 0.0506] 0.0431 3.17e− 05 [0.0315; 0.056] [0.0313; 0.0549]
9 0.0452 3.57e− 05 [0.034; 0.0574] [0.0335; 0.0569] 0.0492 3.57e− 05 [0.0376; 0.0629] [0.0366; 0.0618]
10 0.0476 3.76e− 05 [0.0361; 0.0596] [0.0356; 0.0596] 0.0518 3.76e− 05 [0.0392; 0.0655] [0.0387; 0.0649]
11 0.0502 4.04e− 05 [0.0379; 0.0631] [0.0377; 0.0627] 0.0547 4.04e− 05 [0.0414; 0.0677] [0.0414; 0.0679]
12 0.0512 4.04e− 05 [0.0388; 0.0637] [0.0387; 0.0636] 0.0557 4.04e− 05 [0.0432; 0.0695] [0.0424; 0.0691]
13 0.0520 4.25e− 05 [0.0393; 0.0642] [0.0392; 0.0648] 0.0566 4.25e− 05 [0.0441; 0.0708] [0.0432; 0.07]
14 0.0552 4.42e− 05 [0.0426; 0.068] [0.0422; 0.0683] 0.0601 4.42e− 05 [0.0471; 0.0747] [0.0464; 0.0739]
15 0.0545 4.31e− 05 [0.0413; 0.0669] [0.0416; 0.0673] 0.0593 4.31e− 05 [0.0468; 0.0739] [0.0456; 0.073]
20 0.0452 3.68e− 05 [0.0336; 0.0566] [0.0333; 0.0571] 0.0492 3.68e− 05 [0.037; 0.0632] [0.0365; 0.062]
30 0.0258 2.09e− 05 [0.0174; 0.0346] [0.0168; 0.0347] 0.0280 2.09e− 05 [0.0191; 0.0391] [0.018; 0.0381]
40 0.0176 1.60e− 05 [0.0101; 0.0256] [0.0098; 0.0254] 0.0192 1.60e− 05 [0.0115; 0.028] [0.0108; 0.0275]
50 0.0100 9.03e− 06 [0.0045; 0.0163] [0.0042; 0.0159] 0.0109 9.03e− 06 [0.0055; 0.0179] [0.0046; 0.0173]
Table 4: Estimate of P01(s, t), s = 3 using the new estimator and Meira-Machado estimator, along with bootstrap
95% CIs and CIs based on normal approximation
15
New estimator Meira-Machado estimator
t P01(s, t) Variance Bootstrap CI Normal CI P01(s, t) Variance Bootstrap CI Normal CI
7 0.0167 1.60e− 05 [0.0091; 0.0243] [0.0089; 0.0246] 0.0190 1.60e− 05 [0.0108; 0.0281] [0.0101; 0.0278]
8 0.0208 1.95e− 05 [0.0119; 0.0296] [0.0121; 0.0294] 0.0236 1.95e− 05 [0.0143; 0.0336] [0.0137; 0.0334]
9 0.0286 2.62e− 05 [0.0187; 0.0384] [0.0186; 0.0386] 0.0324 2.62e− 05 [0.0217; 0.0443] [0.021; 0.0438]
10 0.0325 2.99e− 05 [0.0213; 0.0435] [0.0218; 0.0432] 0.0369 2.99e− 05 [0.0255; 0.0498] [0.0248; 0.049]
11 0.0357 3.22e− 05 [0.0241; 0.0471] [0.0246; 0.0468] 0.0405 3.22e− 05 [0.0281; 0.0535] [0.0279; 0.0531]
12 0.0379 3.41e− 05 [0.0262; 0.0494] [0.0264; 0.0493] 0.0430 3.41e− 05 [0.0308; 0.0559] [0.0301; 0.0558]
13 0.0398 3.56e− 05 [0.0278; 0.0512] [0.0281; 0.0515] 0.0452 3.56e− 05 [0.0325; 0.0582] [0.0321; 0.0583]
14 0.0438 4.10e− 05 [0.0309; 0.056] [0.0312; 0.0563] 0.0497 4.10e− 05 [0.036; 0.0644] [0.0361; 0.0633]
15 0.0438 4.17e− 05 [0.0307; 0.0561] [0.0311; 0.0565] 0.0497 4.17e− 05 [0.0363; 0.0633] [0.0359; 0.0635]
20 0.0402 4.01e− 05 [0.0277; 0.0529] [0.0278; 0.0526] 0.0456 4.01e− 05 [0.0324; 0.0593] [0.032; 0.0593]
30 0.0233 2.43e− 05 [0.0139; 0.0336] [0.0136; 0.0329] 0.0264 2.43e− 05 [0.0157; 0.0374] [0.0153; 0.0374]
40 0.0174 1.88e− 05 [0.0096; 0.0264] [0.0088; 0.0259] 0.0196 1.88e− 05 [0.0109; 0.0304] [0.0101; 0.0292]
50 0.0102 1.16e− 05 [0.0042; 0.0175] [0.0035; 0.0168] 0.0115 1.16e− 05 [0.0049; 0.0195] [0.0042; 0.0187]
Table 5: Estimate of P01(s, t), s = 5 using the new estimator and Meira-Machado estimator, along with bootstrap
95% CIs and CIs based on normal approximation
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New estimator Meira-Machado estimator
t P01(s, t) Variance Bootstrap CI Normal CI P01(s, t) Variance Bootstrap CI Normal CI
9 0.0165 2.02e− 05 [0.0087; 0.0266] [0.0077; 0.0253] 0.0192 2.02e− 05 [0.01; 0.0304] [0.0087; 0.0297]
10 0.0215 2.63e− 05 [0.0119; 0.0329] [0.0115; 0.0316] 0.0251 2.63e− 05 [0.0139; 0.0381] [0.013; 0.0371]
11 0.0269 3.33e− 05 [0.0167; 0.0398] [0.0156; 0.0382] 0.0313 3.33e− 05 [0.0186; 0.0459] [0.0178; 0.0447]
12 0.0297 3.61e− 05 [0.0195; 0.0438] [0.0179; 0.0414] 0.0345 3.61e− 05 [0.0218; 0.0494] [0.0206; 0.0484]
13 0.0334 4.16e− 05 [0.0218; 0.0478] [0.0208; 0.0461] 0.0389 4.16e− 05 [0.0248; 0.0546] [0.024; 0.0538]
14 0.0385 4.92e− 05 [0.0257; 0.0546] [0.0248; 0.0523] 0.0448 4.92e− 05 [0.0301; 0.0617] [0.0293; 0.0604]
15 0.0398 5.12e− 05 [0.0267; 0.0554] [0.0258; 0.0538] 0.0463 5.12e− 05 [0.0311; 0.0625] [0.0309; 0.0617]
20 0.0364 4.70e− 05 [0.0229; 0.0514] [0.0229; 0.0498] 0.0424 4.70e− 05 [0.0288; 0.058] [0.0275; 0.0573]
30 0.0245 3.28e− 05 [0.0139; 0.0375] [0.0133; 0.0358] 0.0287 3.28e− 05 [0.0166; 0.0424] [0.0161; 0.0413]
40 0.0209 2.72e− 05 [0.0111; 0.0321] [0.0107; 0.0311] 0.0244 2.72e− 05 [0.0135; 0.0383] [0.0121; 0.0367]
50 0.0130 1.77e− 05 [0.0057; 0.0222] [0.0048; 0.0212] 0.0152 1.77e− 05 [0.0061; 0.0259] [0.0053; 0.025]
Table 6: Estimate of P01(s, t), s = 7 using the new estimator and Meira-Machado estimator, along with bootstrap
95% CIs and CIs based on normal approximation
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t Pˇ01(3, t) Aalen- Pˇ01(5, t) Aalen- Pˇ01(7, t) Aalen-
Johansen Johansen Johansen
5 0.0234 0.0266
6 0.0314 0.0359
7 0.0363 0.0411 0.0167 0.0200
8 0.0396 0.0446 0.0208 0.0250
9 0.0452 0.0515 0.0286 0.0343 0.0165 0.01987
10 0.0476 0.0533 0.0325 0.0376 0.0215 0.02498
11 0.0502 0.0559 0.0357 0.0419 0.0269 0.03141
12 0.0512 0.0569 0.0379 0.0440 0.0297 0.03481
13 0.0520 0.0578 0.0398 0.0460 0.0334 0.03813
14 0.0552 0.0612 0.0438 0.0503 0.0385 0.04389
15 0.0545 0.0605 0.0438 0.0505 0.0398 0.04503
20 0.0452 0.0509 0.0402 0.0445 0.0364 0.04218
30 0.0258 0.0292 0.0233 0.0270 0.0245 0.02726
40 0.0176 0.0204 0.0174 0.0196 0.0209 0.02061
50 0.0100 0.0115 0.0102 0.0111 0.0130 0.01165
Table 7: Point estimates Pˇ01(s, t) as in Tables 4–6 and corresponding Aalen-
Johansen estimates.
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6 Discussion
We have demonstrated how to use competing risks techniques for estimating
transition probabilities in a non-Markov illness-death model without recov-
ery. For ease of presentation, we have focused on estimating P01(s, t). Our
first estimator, Pˆ01(s, t) from (10), is algebraically equal to the estimator of
Meira-Machado et al. (2006) who derived it using Kaplan-Meier integrals.
We have also given a new IPCW representation of the estimator, which
we have then used to find a computationally simpler estimator, Pˇ01(s, t)
from (14).
To discuss the intrinsic properties of the proposed estimators, it is useful
to consider the special case where the process is fully observed for all cases
(uncensored data). Then, transition probabilities can be consistently esti-
mated by ratios of crude counts also when the process is non-Markov. In
fact, for uncensored data both Pˆ01(s, t) and Pˇ01(s, t) reduce to∑n
i=1 1{X
(i)
s = 0, X
(i)
t = 1}∑n
i=1 1{X
(i)
s = 0}
, (15)
where the superscript (i) indicates the ith replicate of n i.i.d. copies of the
multistate process. This is in analogy to many estimators of the state oc-
cupation probabilities which reduce to the usual multinomial estimators for
complete data. In (15), each individual contributes with equal weight 1/n to
the sum in the nominator and in the denominator.
For right-censored data, the status of the process is unknown after the
individual end of study time. From an IPCW perspective, the idea underly-
ing Pˆ01(s, t) is to restrict the summation in (15) to the individuals not lost to
follow-up before time t and to re-weight their contributions by the probabil-
ity of not being lost to follow-up. The weights are based on a Kaplan-Meier
estimate of the censoring distribution using the censored observations of T ,
see (12).
However, some individuals will be lost to follow-up in the initial state
and others in the disease state. This information is not used by Pˆ01(s, t),
but Pˇ01(s, t) uses such information, see (13). Theoretically, Pˇ01(s, t) is there-
fore more efficient, but the simulation results and the practical data example
found comparable performance. The practical advantage of Pˇ01(s, t) is that
it is computationally simpler.
A further advantage of Pˇ01(s, t) is that, being an Aalen-Johansen esti-
mator of the limit of a certain cumulative incidence function, it gives direct
access to competing risks methodology, as we have demonstrated by also
allowing for left-truncated data. In the context of hospital-acquired infec-
tions, such a delayed study entry may arise if patients are not followed since
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admission but conditional on detection of an infectious organism such as
Methicillin-Resistant Staphylococcus Aureus as in De Angelis et al. (2011).
So far, a drawback of the estimation procedures as outlined both in the
present paper and in Meira-Machado et al. (2006) is that we require the sup-
port of the distribution of T to be contained in the support of the distribution
of C in order to be able to estimate the limit of a cumulative incidence func-
tion, see (7). This is not a restriction for our motivating data situation, but
the assumption is often not fulfilled in other medical applications. The prob-
lem can be circumvented by ‘artificial censoring’ black as, e.g., in Quale et al.
(2006).
To be specific, consider the fixed, but arbitrary time pair s ≤ t and assume
that s, t < inf{v : P (C > v) = 0}. Then there is a τ > t with P (C > τ) > 0.
The idea is to consider the modified random variables (min(T0, τ),min(T, τ))
instead of (T0, T ). Their distributions coincide on [0, τ) × [0, τ), which in-
cludes the bivariate time point of interest (s, t), and min(T, τ) is less than
inf{v : P (C > v) = 0} by construction. We can then use the estimation
techniques as outlined earlier, but using the modified data. Note that the
data do change. E.g., if observation of T is censored after the chosen τ , the
modified variable min(T, τ) has been observed.
Finally, our limited simulation study indicated that the Aalen-Johansen
estimator may competitively estimate transition probabilities in small sam-
ples even in the absence of the Markov property. This is not unlike the
findings of Gunnes et al. (2007) for estimating state occupation probabili-
ties.
Appendix
The aim of the appendix is to show that our initial estimation procedure
based on the competing risks process κ is algebraically identical with the
proposal of Meira-Machado et al. (2006). The idea of their estimator is to
consider T0 as a covariate for the event time T and to use Stute’s estimator
for a Kaplan-Meier integral with a covariate (Stute, 1993).
For the purpose of comparison, note that the formulation of Meira-Machado
et al. is based on latent transition times between the states of the illness-death
model. These authors then consider censored variants of such latent times,
provided they are observable. Meira-Machado et al. then arrive at censored
variants of (T0, T ), which will be our starting point. Also note that because
T0 will be considered as a covariate for a Kaplan-Meier integral with respect
to T , we will only need an event indicator for the latter. This will further
simplify the notation. We will also use that T0 has been observed, if T has
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been observed, because T0 ≤ T .
Stute’s method requires that the parameter of interest can be formulated
as an integral with respect to the joint distribution of (T0, T ),∫
φ(z, y) P T0,T ( dz, dy).
Again focussing on P01(s, t) for ease of presentation, the Meira-Machado et
al. estimator relies on estimating the above display for φ(z, y) = 1(s < z ≤
t, t < y).
Assume n i.i.d. data (T˜0i, T˜i, ξi), i = 1, . . . n, where the tilde indicates a
censored observation, e.g., T˜i = min(Ti, Ci), ξi is the event indicator 1(Ti ≤
Ci), and the index i indicates the ith individual. Stute’s method (and the
estimator of Meira-Machado et al.) is based on the ordered data T(1) ≤
. . . ≤ T(n) with (ξ[i], T0[i]) attached to T(i). Again for ease of presentation, we
assume no ties in the data; Stute (1993) discusses how to arbitrarily break
ties if present. Note that our formulation of the estimators does allow for
ties.
The Meira-Machado et al. estimator of P (s < T0 ≤ t, t < T ) is
n∑
i=1
i−1∏
j=1
(
1−
ξ[j]
n− j + 1
)
ξ[i]
n− i+ 1
φ(T0[i], T(i)).
Using the counting process notation introduced earlier, the above display
equals
n∑
i=1
i−1∏
j=1
(
1−
∆N(T˜(j))
Y (T˜(j))
)
∆N(T˜(i))
Y (T˜(i))
φ(T0[i], T(i)).
We note two things about the last display: Firstly, because the sum runs
over all individuals and because addition and multiplication are each com-
mutative, ordering is not needed. Secondly, if ∆N(T˜i) = 1, then T˜i = Ti
and T˜0i = T0i. Hence, we have ∆N(T˜i) · φ(T0i, Ti) = ∆N1(T˜i). As a conse-
quence, the Meira-Machado et al. estimator of P (s < T0 ≤ t, t < T ) equals
our competing risks-type estimator (9) and hence our estimator (10) equals
their estimator of P01(s, t).
References
O. Aalen and S. Johansen, “An empirical transition matrix for non-
homogeneous Markov chains based on censored observations,” Scandina-
vian Journal of Statistics vol. 5 pp. 141–150, 1978.
21
A. Allignol, M. Schumacher and J. Beyersmann, “A note on variance estima-
tion of the Aalen-Johansen estimator of the cumulative incidence function
in competing risks, with a view towards left-truncated data,” Biometrical
Journal vol. 52 pp. 126–137, 2010.
A. Allignol, M. Schumacher and J. Beyersmann, “Estimating summary func-
tionals in multistate models with an application to hospital infection data,”
Computational Statistics vol. 26 pp. 181–197, 2011.
P. Andersen, Ø. Borgan, R. Gill and N. Keiding, Statistical Models Based
on Counting Processes., Springer, New York, 1993.
A. Azzalini, “A class of distributions which includes the normal ones,” Scan-
dinavian Journal of Statistics vol. 12 pp. 171–178, 1985.
J. Beyersmann, A. Allignol and M. Schumacher, Competing Risks and Mul-
tistate Models with R, Springer, New York, 2012.
J. Beyersmann, P. Gastmeier, H. Grundmann, S. Ba¨rwolff, C. Geffers,
M. Behnke, H. Ru¨den and M. Schumacher, “Use of multistate models
to assess prolongation of intensive care unit stay due to nosocomial infec-
tion,” Infection Control and Hospital Epidemiology vol. 27 pp. 493–499,
2006.
J. Beyersmann, M. Wolkewitz, A. Allignol, N. Grambauer and M. Schu-
macher, “Application of multistate models in hospital epidemiology: ad-
vances and challenges,” Biometrical Journal vol. 53 pp. 332–350, 2011.
T. Braun and Z. Yuan, “Comparing the small sample performance of several
variance estimators under competing risks,” Statistics in Medicine vol. 26
pp. 1170–1180, 2007.
S. Datta and A. Ferguson, Recent Advances in System Reliability (eds. A.
Lisnianski and I. Frenkel), chap. Nonparametric Estimation of Marginal
Temporal Functionals in a Multi-State Model, Springer, 2012.
S. Datta and G. A. Satten, “Validity of the Aalen-Johansen estimators of
stage occupation probabilities and Nelson-Aalen estimators of integrated
transition hazards for non-Markov models,” Statistics and Probability Let-
ters vol. 55 pp. 403–411, 2001.
S. Datta and G. A. Satten, “Estimation of integrated transition hazards and
stage occupation probabilities for non-markov systems under dependent
censoring,” Biometrics vol. 58 pp. 792–792, 2002.
22
S. Datta, G. A. Satten and S. Datta, “Nonparametric estimation for the
three-stage irreversible illness-death model,” Biometrics vol. 56 pp. 841–
847, 2000.
G. De Angelis, A. Allignol, A. Murthy, M. Wolkewitz, J. Beyersmann,
E. Safran, J. Schrenzel, D. Pittet and S. Harbarth, “Multistate modelling
to estimate the excess length of stay associated with meticillin-resistant
staphylococcus aureus colonisation and infection in surgical patients,”
Journal of Hospital Infection vol. 78 pp. 86–91, 2011.
J. Fine, H. Jiang and R. Chappell, “On semi-competing risks data,”
Biometrika pp. 907–919, 2001.
R. Gill, “Multivariate survival analysis.” Theory of Probability and its Ap-
plications vol. 37 pp. 18–31, 1992.
D. Glidden, “Robust inference for event probabilities with non-Markov data,”
Biometrics vol. 58 pp. 361–368, 2002.
N. Grambauer, M. Schumacher, M. Dettenkofer and J. Beyersmann, “In-
cidence densities in a competing events analysis,” American Journal of
Epidemiology vol. 172 pp. 1077–1084, 2010.
N. Graves, A. Barnett, K. Halton, C. Crnich, B. Cooper, J. Beyersmann,
M. Wolkewitz, M. Samore and S. Harbarth, “The importance of good
data, analysis, and interpretation for showing the economics of reducing
healthcare-associated infection,” Infection Control and Hospital Epidemi-
ology vol. 32 pp. 927–928, 2011.
N. Gunnes, Ø. Borgan and O. Aalen, “Estimating stage occupation proba-
bilities in non-markov models,” Lifetime data analysis vol. 13 pp. 211–240,
2007.
N. Keiding, “Independent delayed entry. In Klein, J. and Goel, P., editors,”
Survival analysis: state of the art, Kluwer, Dordrecht pp. 309–326, 1992.
D. Lin and Z. Ying, “A simple nonparametric estimator of the bivariate
survival function under univariate censoring,” Biometrika vol. 80 pp. 573–
581, 1993.
L. Meira-Machado, J. de Un˜a-A´lvarez and C. Cadarso-Sua´rez, “Nonpara-
metric estimation of transition probabilities in a non-Markov illness-death
model,” Lifetime Data Analysis vol. 12 pp. 325–344, 2006.
23
M. Pepe, G. Longton and M. Thornquist, “A qualifier q for the survival
function to describe the prevalence of a transient condition,” Statistics in
Medicine vol. 10 pp. 413–421, 1991.
R. Prentice, Z. Moodie and J. Wu, “Nonparametric estimation of the bivari-
ate survivor function.” in D. Lin and P. Heagerty (eds.) “Proceedings of the
second Seattle Symposium in Biostatistics,” , Lecture notes in statistics,
vol. 179pp. 113–142, New York, NY: Springer, 2004.
C. Quale, M. van der Laan and R. Robins, “Locally efficient estimation
with bivariate right-censored data,” Journal of the American Statistical
Assocation vol. 101 pp. 1076–1084, 2006.
W. Stute, “Consistent estimation under random censorship when covariables
are present.” Journal of Multivariate Statistics vol. 45 pp. 89–103, 1993.
W. Tsai and J. Crowley, “A note on nonparametric estimators of the bivariate
survival function under univariate censoring.” Biometrika vol. 85 pp. 573–
580, 1998.
C. Umscheid, M. Mitchell, J. Doshi, R. Agarwal, K. Williams and P. Bren-
nan, “Estimating the proportion of healthcare-associated infections that
are reasonably preventable and the related mortality and costs,” Infection
Control and Hospital Epidemiology vol. 32 pp. 101–114, 2011.
M. J. van der Laan and J. M. Robins, Unified methods for censored longitu-
dinal data and causality, New York, NY: Springer, 2003.
24
